Breast cancer overdiagnosis in mammography trials-separating signal from noise: a meta-analysis.
Estimates of breast cancer overdiagnosis from randomized mammography trials range from ∼0 to ∼50%, reflecting methodological inconsistencies including handling of exit screening and post-screening compensatory drops. A coherent framework for interpreting trial results is needed to aid clinical counselling and guideline development.
Estimates of breast cancer overdiagnosis from randomized mammography trials range from ∼0 to ∼50%, reflecting methodological inconsistencies including handling of exit screening and post-screening compensatory drops. A coherent framework for interpreting trial results is needed to aid clinical counselling and guideline development.
What the study was
- Study design
- Randomized Controlled Trial (inferred)
- Category
- Diagnostics
- Maturity
- Potentially Practice-Changing
- Journal
- J Natl Cancer Inst
Why it surfaced
Sentinel scan match. Study design: Randomized Controlled Trial (inferred). Score: 8/10 (N:1, R:3, D:2, P:2).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.